On September 17, 2018, the Senate passed its opioid package of 70 bills, with a 99 to 1 vote. It includes provisions that would advance the research and development of non-addictive painkillers, help prevent synthetic opioids like fentanyl from entering the country’s mail system and authorize various grants for prevention treatment and recovery support services. The Senate bill also includes provisions to reauthorize the Office of National Drug Control Policy and its two programs, Drug Free Communities and High Intensity Drug Trafficking Areas.
The House passed its opioid package on June 22, 2018.
The House and the Senate will now assign conferees to work together and sort out differences in each chamber's opioid package. Once a final conference bill is ready, both chambers will vote again, then send the bill to the President's desk to be signed into law.